. This example of a real-world community-based clinical trial is part of a program of ongoing studies to evaluate the safety and efficacy of accessible and cost-effective potential drug therapies for SARS-CoV-2 infection [22]. Currently, the PRINCIPLE molnupiravir trial has recruited more than...
In contrast to antibody agents, small-molecule antivirals hold several advantages, including better pharmacokinetics, administration, cost-effectiveness, scalability in production, and ease of storage and transportation [21]. Currently, small-molecule antiviral drugs, Paxlovid (Ritonavir-Boosted Nirmatre...